Received Jun 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | LA |
nurse gave Penmenvy without mixing. So, patient only got the MenB portion; nurse gave Penmenvy without mixing. So, patient only got the MenB portion; This non-serious case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a 16-year-old male patient who received Men ABCWY NVS (Penmenvy) suspension for injection in pre-filled syringe for prophylaxis. On 21-MAY-2026, the patient received the 1st dose of Penmenvy (left deltoid). On 21-MAY-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: nurse gave Penmenvy without mixing. So, patient only got the MenB portion) and inappropriate dose of vaccine administered (Verbatim: nurse gave Penmenvy without mixing. So, patient only got the MenB portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 27-MAY-2026 The batch number was not provided upon follow up with the reporter.